Explore other Johns Hopkins Sites
Wilmer Eye Institute at Johns Hopkins
 
 
 
 
Wilmer Eye Institute
 

Jampel, Henry David

Henry D. Jampel, M.D., MHSHenry D. Jampel, MD, MHS

Maumenee B-117
Johns Hopkins Hospital
600 N. Wolfe St.
Baltimore, MD 21287-9205

Phone: 410/955-6082
Fax: 410/502-7493
E-mail: hjampel@jhmi.edu

Dr. Henry Jampel, Odd Fellows and Rebekahs Professor of Ophthalmology, has been a member of the Glaucoma Division since 1988. He received his bachelor's degree in Biology, summa cum laude, from Harvard College, and subsequently attended the Yale University School of Medicine. Dr. Jampel pursued both his ophthalmology residency training and glaucoma fellowship at the Wilmer Institute, and was then invited to join the faculty. In 1996 he received a Master's degree in Health Finance and Administration.

Clinically, Dr. Jampel treats glaucoma patients of all ages. In addition to the standard glaucoma operations he also has a special interest in combined cataract and glaucoma surgery, drainage device surgery, and ciliodestructive procedures for the more complicated and more unusual glaucomas. He is the medical director of the The Wilmer Eye Institute at Greenspring Station.

Dr. Jampel's research interests include patient-oriented outcomes of glaucoma treatment and detection of glaucoma progression. He is the Principal Investigator of a National Eye Institute funded study to determine if changes in the thickness of the retina can predict visual field loss in glaucoma.

Dr. Jampel serves as Associate Editor-in-Chief of Ophthalmology, one of the premier journals in the field, and the official journal of the American Academy of Ophthalmology (AAO). He also serves on the Preferred Practice Committee of the AAO for glaucoma and on the Eye Health and Information Task Force of the AAO.

In his spare time, Dr. Jampel spends time with his wife, Risa, a dermatologist recently designated as one of Baltimore's best doctors, and his three children, Catherine, Joseph, and Sarah. He completed the Ironman World Triathlon Championship in Kailua-Kona, Hawaii, in 1999 and continues to race competitively as a triathlete.

>Read Dr. Jampel's complete CV

 
 
 
 
Controversy Swirls Around Lucentis

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

About John Hopkins - Find Out More

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries